Immunological effect of co-trimoxazole on platelets.
- 13 October 1979
- Vol. 2 (6195) , 898-899
- https://doi.org/10.1136/bmj.2.6195.898
Abstract
Diminished survival of transfused platelets occurred in two patients given co-trimoxazole, and a third patient taking this drug developed thrombocytopenia. By means of an indirect immunofluorescence assay antibodies against donor platelets coated with co-trimoxazole were found in the sera in all cases. These antibodies were directed against the trimethoprim component of co-trimoxazole and not against sulphamethoxazole. Co-trimoxazole is a potent antimicrobial agent and is advocated for treatment and prophylaxis in leukaemia. Hence its adverse effect on platelets is of great importance.Keywords
This publication has 7 references indexed in Scilit:
- CO-TRIMOXAZOLE FOR PREVENTION OF INFECTION IN ACUTE LEUKÆMIAThe Lancet, 1978
- Regulation of RespirationNew England Journal of Medicine, 1977
- Detection of drug‐dependent antibodies by the 51cr platelet lysis test: Documentation of immune thrombocytopenia induced by diphenylhydantoin, diazepam, and sulfisoxazoleAmerican Journal of Hematology, 1977
- Rifampicin-induced Immune ThrombocytopeniaBMJ, 1970
- Plasmodium berghei dihydrofolate reductase. Isolation, properties, and inhibition by antifolates.1969
- TRIMETHOPRIM, A SULPHONAMIDE POTENTIATORBritish Journal of Pharmacology, 1968
- IMMUNOREACTIONS INVOLVING PLATELETSThe Journal of Experimental Medicine, 1958